Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1022 studies found for:    Open Studies | "Genital Diseases, Male"
Show Display Options
Rank Status Study
21 Recruiting Study of Metformin With Simvastatin for Men With Prostate Carcinoma
Condition: Prostate Carcinoma
Interventions: Drug: Metformin;   Drug: Simvastatin
22 Recruiting Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
Conditions: Nocturia;   Benign Prostatic Hyperplasia
Interventions: Drug: Silodosin;   Other: Laboratory tests;   Other: 3-days voiding diary;   Other: 12 weeks
23 Not yet recruiting Contrast Enhanced MRI of the Prostate
Condition: Prostatic Neoplasms
Intervention:
24 Recruiting Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Leuprolide acetate;   Radiation: radiation
25 Recruiting Stress Management for Couples Undergoing In Vitro Fertilization (IVF)
Condition: Infertility
Interventions: Behavioral: Stress Management & Resiliency Training;   Behavioral: Stress Management DVD
26 Recruiting Eban II: Intervention for HIV Sero-Discordant Couples
Conditions: Sexually Transmitted Diseases;   Disease Transmission, Infectious;   Safe Sex;   HIV
Intervention: Behavioral: Risk Reduction
27 Recruiting Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS)
Condition: Prostate Cancer
Intervention: Behavioral: PROGRESS
28 Unknown  Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: RAD001
29 Unknown  Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer
Condition: Prostate Cancer
Intervention:
30 Not yet recruiting Development of Circulating Molecular Predictors of Chemotherapy and Novel Hormonal Therapy Benefit in Men With Metastatic Castration Resistant Prostate Cancer (mCRPC) (PCF)
Condition: Prostate Cancer
Intervention: Device: AR-v7 assays
31 Not yet recruiting A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
Condition: Gonorrhea
Intervention: Drug: GSK2140944
32 Recruiting A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Condition: Metastatic Castration-Resistant Prostate Cancer
Intervention: Drug: Enzalutamide
33 Unknown  Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention
Conditions: HIV Infections;   Hepatitis;   Sexually Transmitted Infections
Interventions: Behavioral: Traditional Prevention;   Behavioral: Web-based Prevention
34 Recruiting Degarelix Neo-Adjuvant Radical Prostatectomy Trial
Condition: Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Casodex;   Drug: LHRH Agonist
35 Recruiting Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)
Condition: Metastatic Castration Resistant Prostate Cancer (CRPC)
Intervention: Drug: Hamsa-1™ TL-118
36 Recruiting Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
Condition: Low Risk Prostate Cancer
Intervention: Behavioral: assessments
37 Unknown  Imaging for Significant Prostate Cancer Risk Evaluation
Condition: Prostate Cancer
Interventions: Procedure: Prostate HistoScanning;   Procedure: Multi-parametric MRI;   Procedure: Transperineal prostate mapping biopsy;   Procedure: Image guided biopsies
38 Recruiting Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy
Condition: Metastatic Castration Sensitive Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Ipilimumab;   Procedure: Radical Prostatectomy
39 Recruiting Immune Monitoring on Sipuleucel-T
Condition: Prostate Cancer
Intervention:
40 Recruiting Radium-223 Dichloride (Ra-223 Cl2) Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis
Condition: Prostatic Neoplasms
Intervention: Drug: Radium-223 dichloride (Xofigo, BAY88-8223)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years